Loading…

Eli Lilly announced a $3 billion expansion of its Kenosha County, Wisconsin manufacturing facility, acquired earlier in 2024, to boost production of injectable medicines for diabetes, obesity and other areas. The expansion will add 750 jobs and start construction in 2025.
“Today's announcement represents our single largest U.S. manufacturing investment outside our home state of Indiana and will add to our ability to expand capacity to make both our existing and future pipeline of medicines right here in the Midwest.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.